Sort
30,917 grants matching “tumor microenvironment”
Cellular In vivo Imaging
$1,153,574Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Induction of an Antitumor Immune Response in Patients with Melanoma
$1,153,528Patrick Hwu · University Of Tx Md Anderson Can Ctr · P50 · FY2012 · CA
DISRUPTION OF THE TUMOR MICROENVIRONMENT IN HER2+ BREAST TO BRAIN METASTASIS
$1,152,659University Of Southern California · · FY2015 · Department of the Army
1/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership
$1,152,375Brian M. Rivers · Morehouse School Of Medicine · U54 · FY2023 · CA
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
$1,151,937Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Nuclear Structure and Gene Expression
$1,151,740Gary S. Stein · Univ Of Massachusetts Med Sch Worcester · P01 · FY2007 · CA
Preclinical Mouse Models for Studying Immune Checkpoint Inhibitor Response
$1,151,331Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis
$1,151,039Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer
$1,151,039Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Vermont PROSPR Research Center (VPRC)
$1,150,391Brian L Sprague · University Of Vermont & St Agric College · U54 · FY2013 · CA
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform
$1,150,319Shawn Hingtgen · Univ Of North Carolina Chapel Hill · U01 · FY2022 · TR
Nuclear Structure and Gene Expression
$1,150,000Gary S. Stein · Univ Of Massachusetts Med Sch Worcester · P01 · FY2006 · CA
Pediatric Solid Tumor Microenvironment Atlas
$1,149,870Shahab Asgharzadeh · Children'S Hospital Of Los Angeles · U01 · FY2024 · CA
Dynamic State Space Modeling of Cancer Cell Response to Therapy
$1,149,496Garry P Nolan · University Of Southern California · U54 · FY2013 · CA
Growth Factor/Extracellular Matrix Interactions During Branching Morphogenesis
$1,149,411Matthew Hoffman · National Institute Of Dental & Craniofacial Research · ZIA · FY2017 · DE
Development of CA-IL-12 for Triple Negative Breast Cancer
$1,148,542Edward J Filardo · Cytonus Therapeutics, Inc. · R44 · FY2023 · CA
Studies of Human T Regulatory Cells
$1,148,221Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Biomarkers in Cancer Diagnosis, Prognosis and Therapeutic Outcome
$1,147,757Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Childhood Cancer Data Initiative
$1,147,549Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZID · FY2025 · CA
Immuno/Immuno-Gene Therapies for Thoracic Malignancies
$1,147,325Steven Mark Albelda · University Of Pennsylvania · P01 · FY2014 · CA
SBIR: In vivo engineering of multifaceted B7H3.CAR-T cells for cellular immunotherapy of pancreatic ductal adenocarcinoma
$1,146,618Ming Yang · Mucommune, Llc · R44 · FY2025 · CA
Insights from Asian Populations into Disparities in Breast Cancer Prognosis and Outcomes
$1,145,972Scarlett L Gomez · University Of California, San Francisco · R01 · FY2020 · CA
Molecular signatures for liver cancer diagnosis and treatment stratification
$1,145,964Xin Wei Wang · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Rapid highly multi-plexed immuno-profiling of solid tumors by SpectralEdge imaging
$1,145,798Eric Kaldjian · Rarecyte, Inc. · R44 · FY2020 · CA
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma
$1,145,739Guido Erwin Michael Eibl · University Of California Los Angeles · P01 · FY2021 · CA